IBDEI06C ; ; 01-AUG-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15368,2)
 ;;=^5001908
 ;;^UTILITY(U,$J,358.3,15369,0)
 ;;=C45.0^^56^644^175
 ;;^UTILITY(U,$J,358.3,15369,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15369,1,3,0)
 ;;=3^Mesothelioma of Pleura
 ;;^UTILITY(U,$J,358.3,15369,1,4,0)
 ;;=4^C45.0
 ;;^UTILITY(U,$J,358.3,15369,2)
 ;;=^5001095
 ;;^UTILITY(U,$J,358.3,15370,0)
 ;;=C90.01^^56^644^177
 ;;^UTILITY(U,$J,358.3,15370,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15370,1,3,0)
 ;;=3^Multiple Myeloma,In Remission
 ;;^UTILITY(U,$J,358.3,15370,1,4,0)
 ;;=4^C90.01
 ;;^UTILITY(U,$J,358.3,15370,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,15371,0)
 ;;=C90.00^^56^644^178
 ;;^UTILITY(U,$J,358.3,15371,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15371,1,3,0)
 ;;=3^Multiple Myeloma,Not in Remission
 ;;^UTILITY(U,$J,358.3,15371,1,4,0)
 ;;=4^C90.00
 ;;^UTILITY(U,$J,358.3,15371,2)
 ;;=^5001752
 ;;^UTILITY(U,$J,358.3,15372,0)
 ;;=C94.6^^56^644^179
 ;;^UTILITY(U,$J,358.3,15372,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15372,1,3,0)
 ;;=3^Myelodysplastic Disease NEC
 ;;^UTILITY(U,$J,358.3,15372,1,4,0)
 ;;=4^C94.6
 ;;^UTILITY(U,$J,358.3,15372,2)
 ;;=^5001846
 ;;^UTILITY(U,$J,358.3,15373,0)
 ;;=D61.82^^56^644^180
 ;;^UTILITY(U,$J,358.3,15373,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15373,1,3,0)
 ;;=3^Myelophthisis
 ;;^UTILITY(U,$J,358.3,15373,1,4,0)
 ;;=4^D61.82
 ;;^UTILITY(U,$J,358.3,15373,2)
 ;;=^334037
 ;;^UTILITY(U,$J,358.3,15374,0)
 ;;=D47.9^^56^644^181
 ;;^UTILITY(U,$J,358.3,15374,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15374,1,3,0)
 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior
 ;;^UTILITY(U,$J,358.3,15374,1,4,0)
 ;;=4^D47.9
 ;;^UTILITY(U,$J,358.3,15374,2)
 ;;=^5002260
 ;;^UTILITY(U,$J,358.3,15375,0)
 ;;=D53.9^^56^644^185
 ;;^UTILITY(U,$J,358.3,15375,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15375,1,3,0)
 ;;=3^Nutritional Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,15375,1,4,0)
 ;;=4^D53.9
 ;;^UTILITY(U,$J,358.3,15375,2)
 ;;=^5002298
 ;;^UTILITY(U,$J,358.3,15376,0)
 ;;=D47.4^^56^644^186
 ;;^UTILITY(U,$J,358.3,15376,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15376,1,3,0)
 ;;=3^Osteomyelofibrosis
 ;;^UTILITY(U,$J,358.3,15376,1,4,0)
 ;;=4^D47.4
 ;;^UTILITY(U,$J,358.3,15376,2)
 ;;=^5002259
 ;;^UTILITY(U,$J,358.3,15377,0)
 ;;=D51.3^^56^644^210
 ;;^UTILITY(U,$J,358.3,15377,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15377,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Other
 ;;^UTILITY(U,$J,358.3,15377,1,4,0)
 ;;=4^D51.3
 ;;^UTILITY(U,$J,358.3,15377,2)
 ;;=^5002287
 ;;^UTILITY(U,$J,358.3,15378,0)
 ;;=D77.^^56^644^62
 ;;^UTILITY(U,$J,358.3,15378,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15378,1,3,0)
 ;;=3^Disorder of Blood/Blood-Forming Organs in Diseases Classified Elsewhere,Other
 ;;^UTILITY(U,$J,358.3,15378,1,4,0)
 ;;=4^D77.
 ;;^UTILITY(U,$J,358.3,15378,2)
 ;;=^5002396
 ;;^UTILITY(U,$J,358.3,15379,0)
 ;;=D58.2^^56^644^88
 ;;^UTILITY(U,$J,358.3,15379,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15379,1,3,0)
 ;;=3^Hemoglobinopathies,Other
 ;;^UTILITY(U,$J,358.3,15379,1,4,0)
 ;;=4^D58.2
 ;;^UTILITY(U,$J,358.3,15379,2)
 ;;=^87629
 ;;^UTILITY(U,$J,358.3,15380,0)
 ;;=C88.8^^56^644^110
 ;;^UTILITY(U,$J,358.3,15380,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15380,1,3,0)
 ;;=3^Malig Immunoproliferative Diseases,Other
 ;;^UTILITY(U,$J,358.3,15380,1,4,0)
 ;;=4^C88.8
 ;;^UTILITY(U,$J,358.3,15380,2)
 ;;=^5001750
 ;;^UTILITY(U,$J,358.3,15381,0)
 ;;=D70.8^^56^644^183
 ;;^UTILITY(U,$J,358.3,15381,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15381,1,3,0)
 ;;=3^Neutropenia,Other
 ;;^UTILITY(U,$J,358.3,15381,1,4,0)
 ;;=4^D70.8
 ;;^UTILITY(U,$J,358.3,15381,2)
 ;;=^334042
 ;;^UTILITY(U,$J,358.3,15382,0)
 ;;=D59.4^^56^644^184
 ;;^UTILITY(U,$J,358.3,15382,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15382,1,3,0)
 ;;=3^Nonautoimmune Hemolytic Anemias,Other
 ;;^UTILITY(U,$J,358.3,15382,1,4,0)
 ;;=4^D59.4
 ;;^UTILITY(U,$J,358.3,15382,2)
 ;;=^5002326
 ;;^UTILITY(U,$J,358.3,15383,0)
 ;;=D69.59^^56^644^190
 ;;^UTILITY(U,$J,358.3,15383,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15383,1,3,0)
 ;;=3^Secondary Thrombocytopenia,Other
 ;;^UTILITY(U,$J,358.3,15383,1,4,0)
 ;;=4^D69.59
 ;;^UTILITY(U,$J,358.3,15383,2)
 ;;=^5002369
 ;;^UTILITY(U,$J,358.3,15384,0)
 ;;=C22.7^^56^644^51
 ;;^UTILITY(U,$J,358.3,15384,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15384,1,3,0)
 ;;=3^Carcinomas of Liver,Other Spec
 ;;^UTILITY(U,$J,358.3,15384,1,4,0)
 ;;=4^C22.7
 ;;^UTILITY(U,$J,358.3,15384,2)
 ;;=^5000938
 ;;^UTILITY(U,$J,358.3,15385,0)
 ;;=D75.89^^56^644^61
 ;;^UTILITY(U,$J,358.3,15385,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15385,1,3,0)
 ;;=3^Diseases of Blood/Blood-Forming Organs,Other Spec
 ;;^UTILITY(U,$J,358.3,15385,1,4,0)
 ;;=4^D75.89
 ;;^UTILITY(U,$J,358.3,15385,2)
 ;;=^5002392
 ;;^UTILITY(U,$J,358.3,15386,0)
 ;;=D47.Z9^^56^644^182
 ;;^UTILITY(U,$J,358.3,15386,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15386,1,3,0)
 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior,Other
 ;;^UTILITY(U,$J,358.3,15386,1,4,0)
 ;;=4^D47.Z9
 ;;^UTILITY(U,$J,358.3,15386,2)
 ;;=^5002262
 ;;^UTILITY(U,$J,358.3,15387,0)
 ;;=D05.82^^56^644^39
 ;;^UTILITY(U,$J,358.3,15387,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15387,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Other Spec Type
 ;;^UTILITY(U,$J,358.3,15387,1,4,0)
 ;;=4^D05.82
 ;;^UTILITY(U,$J,358.3,15387,2)
 ;;=^5001934
 ;;^UTILITY(U,$J,358.3,15388,0)
 ;;=D05.81^^56^644^41
 ;;^UTILITY(U,$J,358.3,15388,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15388,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,15388,1,4,0)
 ;;=4^D05.81
 ;;^UTILITY(U,$J,358.3,15388,2)
 ;;=^5001933
 ;;^UTILITY(U,$J,358.3,15389,0)
 ;;=D05.80^^56^644^43
 ;;^UTILITY(U,$J,358.3,15389,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15389,1,3,0)
 ;;=3^Carcinoma in Situ Unspec Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,15389,1,4,0)
 ;;=4^D05.80
 ;;^UTILITY(U,$J,358.3,15389,2)
 ;;=^5001932
 ;;^UTILITY(U,$J,358.3,15390,0)
 ;;=D56.8^^56^644^205
 ;;^UTILITY(U,$J,358.3,15390,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15390,1,3,0)
 ;;=3^Thalassemias,Other
 ;;^UTILITY(U,$J,358.3,15390,1,4,0)
 ;;=4^D56.8
 ;;^UTILITY(U,$J,358.3,15390,2)
 ;;=^5002305
 ;;^UTILITY(U,$J,358.3,15391,0)
 ;;=C82.89^^56^644^81
 ;;^UTILITY(U,$J,358.3,15391,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15391,1,3,0)
 ;;=3^Follicular Lymphoma,Extranodal/Solid Organ Sites,Other Types
 ;;^UTILITY(U,$J,358.3,15391,1,4,0)
 ;;=4^C82.89
 ;;^UTILITY(U,$J,358.3,15391,2)
 ;;=^5001540
 ;;^UTILITY(U,$J,358.3,15392,0)
 ;;=D51.8^^56^644^212
 ;;^UTILITY(U,$J,358.3,15392,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15392,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemias,Other
 ;;^UTILITY(U,$J,358.3,15392,1,4,0)
 ;;=4^D51.8
 ;;^UTILITY(U,$J,358.3,15392,2)
 ;;=^5002288
 ;;^UTILITY(U,$J,358.3,15393,0)
 ;;=I80.9^^56^644^187
 ;;^UTILITY(U,$J,358.3,15393,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15393,1,3,0)
 ;;=3^Phlebitis/Thrombophlebitis,Unspec Site
 ;;^UTILITY(U,$J,358.3,15393,1,4,0)
 ;;=4^I80.9
 ;;^UTILITY(U,$J,358.3,15393,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,15394,0)
 ;;=D45.^^56^644^188
 ;;^UTILITY(U,$J,358.3,15394,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15394,1,3,0)
 ;;=3^Polycythemia Vera
 ;;^UTILITY(U,$J,358.3,15394,1,4,0)
 ;;=4^D45.
 ;;^UTILITY(U,$J,358.3,15394,2)
 ;;=^96105
 ;;^UTILITY(U,$J,358.3,15395,0)
 ;;=C77.3^^56^644^117
 ;;^UTILITY(U,$J,358.3,15395,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15395,1,3,0)
 ;;=3^Malig Neop Axilla/Upper Limb Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,15395,1,4,0)
 ;;=4^C77.3
 ;;^UTILITY(U,$J,358.3,15395,2)
 ;;=^5001330
 ;;^UTILITY(U,$J,358.3,15396,0)
 ;;=C77.2^^56^644^133
 ;;^UTILITY(U,$J,358.3,15396,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15396,1,3,0)
 ;;=3^Malig Neop Intra-Abdominal Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,15396,1,4,0)
 ;;=4^C77.2
 ;;^UTILITY(U,$J,358.3,15396,2)
 ;;=^267316
 ;;^UTILITY(U,$J,358.3,15397,0)
 ;;=C77.1^^56^644^134
 ;;^UTILITY(U,$J,358.3,15397,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15397,1,3,0)
 ;;=3^Malig Neop Intrathoracic Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,15397,1,4,0)
 ;;=4^C77.1
 ;;^UTILITY(U,$J,358.3,15397,2)
 ;;=^267315
 ;;^UTILITY(U,$J,358.3,15398,0)
 ;;=C77.0^^56^644^150
 ;;^UTILITY(U,$J,358.3,15398,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15398,1,3,0)
 ;;=3^Malig Neop Nodes of Head,Face and Neck,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,15398,1,4,0)
 ;;=4^C77.0
 ;;^UTILITY(U,$J,358.3,15398,2)
 ;;=^5001329
 ;;^UTILITY(U,$J,358.3,15399,0)
 ;;=C77.8^^56^644^151
 ;;^UTILITY(U,$J,358.3,15399,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15399,1,3,0)
 ;;=3^Malig Neop Nodes of Multiple Regions,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,15399,1,4,0)
 ;;=4^C77.8
 ;;^UTILITY(U,$J,358.3,15399,2)
 ;;=^5001332
 ;;^UTILITY(U,$J,358.3,15400,0)
 ;;=C79.51^^56^644^121
 ;;^UTILITY(U,$J,358.3,15400,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15400,1,3,0)
 ;;=3^Malig Neop Bone,Secondary
 ;;^UTILITY(U,$J,358.3,15400,1,4,0)
 ;;=4^C79.51
 ;;^UTILITY(U,$J,358.3,15400,2)
 ;;=^5001350
 ;;^UTILITY(U,$J,358.3,15401,0)
 ;;=C79.52^^56^644^120
 ;;^UTILITY(U,$J,358.3,15401,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15401,1,3,0)
 ;;=3^Malig Neop Bone Marrow,Secondary
 ;;^UTILITY(U,$J,358.3,15401,1,4,0)
 ;;=4^C79.52
 ;;^UTILITY(U,$J,358.3,15401,2)
 ;;=^5001351
 ;;^UTILITY(U,$J,358.3,15402,0)
 ;;=C79.31^^56^644^122
 ;;^UTILITY(U,$J,358.3,15402,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15402,1,3,0)
 ;;=3^Malig Neop Brain,Secondary
 ;;^UTILITY(U,$J,358.3,15402,1,4,0)
 ;;=4^C79.31
 ;;^UTILITY(U,$J,358.3,15402,2)
 ;;=^5001347
 ;;^UTILITY(U,$J,358.3,15403,0)
 ;;=C79.72^^56^644^137
 ;;^UTILITY(U,$J,358.3,15403,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15403,1,3,0)
 ;;=3^Malig Neop Left Adrenal Gland,Secondary
 ;;^UTILITY(U,$J,358.3,15403,1,4,0)
 ;;=4^C79.72
 ;;^UTILITY(U,$J,358.3,15403,2)
 ;;=^5001357
 ;;^UTILITY(U,$J,358.3,15404,0)
 ;;=C78.02^^56^644^141
 ;;^UTILITY(U,$J,358.3,15404,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15404,1,3,0)
 ;;=3^Malig Neop Left Lung,Secondary
 ;;^UTILITY(U,$J,358.3,15404,1,4,0)
 ;;=4^C78.02
 ;;^UTILITY(U,$J,358.3,15404,2)
 ;;=^5001336
 ;;^UTILITY(U,$J,358.3,15405,0)
 ;;=C78.7^^56^644^146
 ;;^UTILITY(U,$J,358.3,15405,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15405,1,3,0)
 ;;=3^Malig Neop Liver/Intrahepatic Bile Duct,Secondary
 ;;^UTILITY(U,$J,358.3,15405,1,4,0)
 ;;=4^C78.7
 ;;^UTILITY(U,$J,358.3,15405,2)
 ;;=^5001339
 ;;^UTILITY(U,$J,358.3,15406,0)
 ;;=C79.71^^56^644^159
 ;;^UTILITY(U,$J,358.3,15406,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15406,1,3,0)
 ;;=3^Malig Neop Right Adrenal Gland,Secondary
 ;;^UTILITY(U,$J,358.3,15406,1,4,0)
 ;;=4^C79.71
 ;;^UTILITY(U,$J,358.3,15406,2)
 ;;=^5001356
 ;;^UTILITY(U,$J,358.3,15407,0)
 ;;=C78.01^^56^644^163
 ;;^UTILITY(U,$J,358.3,15407,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15407,1,3,0)
 ;;=3^Malig Neop Right Lung,Secondary
 ;;^UTILITY(U,$J,358.3,15407,1,4,0)
 ;;=4^C78.01
 ;;^UTILITY(U,$J,358.3,15407,2)
 ;;=^5001335
 ;;^UTILITY(U,$J,358.3,15408,0)
 ;;=C79.70^^56^644^114
 ;;^UTILITY(U,$J,358.3,15408,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15408,1,3,0)
 ;;=3^Malig Neop Adrenal Gland Unspec,Secondary
 ;;^UTILITY(U,$J,358.3,15408,1,4,0)
 ;;=4^C79.70
 ;;^UTILITY(U,$J,358.3,15408,2)
 ;;=^5001355
 ;;^UTILITY(U,$J,358.3,15409,0)
 ;;=C78.00^^56^644^147
 ;;^UTILITY(U,$J,358.3,15409,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15409,1,3,0)
 ;;=3^Malig Neop Lung Unspec,Secondary
 ;;^UTILITY(U,$J,358.3,15409,1,4,0)
 ;;=4^C78.00
 ;;^UTILITY(U,$J,358.3,15409,2)
 ;;=^5001334
 ;;^UTILITY(U,$J,358.3,15410,0)
 ;;=D57.1^^56^644^191
 ;;^UTILITY(U,$J,358.3,15410,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15410,1,3,0)
 ;;=3^Sickle-Cell Disease w/o Crisis
 ;;^UTILITY(U,$J,358.3,15410,1,4,0)
 ;;=4^D57.1
 ;;^UTILITY(U,$J,358.3,15410,2)
 ;;=^5002309
 ;;^UTILITY(U,$J,358.3,15411,0)
 ;;=D75.1^^56^644^189
 ;;^UTILITY(U,$J,358.3,15411,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15411,1,3,0)
 ;;=3^Polycythemia,Secondary
 ;;^UTILITY(U,$J,358.3,15411,1,4,0)
 ;;=4^D75.1
 ;;^UTILITY(U,$J,358.3,15411,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,15412,0)
 ;;=C90.30^^56^644^202
 ;;^UTILITY(U,$J,358.3,15412,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15412,1,3,0)
 ;;=3^Solitary Plasmacytoma,Not in Remission
 ;;^UTILITY(U,$J,358.3,15412,1,4,0)
 ;;=4^C90.30
 ;;^UTILITY(U,$J,358.3,15412,2)
 ;;=^5001759
 ;;^UTILITY(U,$J,358.3,15413,0)
 ;;=D56.3^^56^644^203
 ;;^UTILITY(U,$J,358.3,15413,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15413,1,3,0)
 ;;=3^Thalassemia Minor
 ;;^UTILITY(U,$J,358.3,15413,1,4,0)
 ;;=4^D56.3
 ;;^UTILITY(U,$J,358.3,15413,2)
 ;;=^340497
 ;;^UTILITY(U,$J,358.3,15414,0)
 ;;=D56.9^^56^644^204
 ;;^UTILITY(U,$J,358.3,15414,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15414,1,3,0)
 ;;=3^Thalassemia,Unspec
 ;;^UTILITY(U,$J,358.3,15414,1,4,0)
 ;;=4^D56.9
 ;;^UTILITY(U,$J,358.3,15414,2)
 ;;=^340606
 ;;^UTILITY(U,$J,358.3,15415,0)
 ;;=D51.2^^56^644^207
 ;;^UTILITY(U,$J,358.3,15415,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15415,1,3,0)
 ;;=3^Transcobalamin II Deficiency
 ;;^UTILITY(U,$J,358.3,15415,1,4,0)
 ;;=4^D51.2
 ;;^UTILITY(U,$J,358.3,15415,2)
 ;;=^5002286
 ;;^UTILITY(U,$J,358.3,15416,0)
 ;;=D05.92^^56^644^40
 ;;^UTILITY(U,$J,358.3,15416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15416,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,15416,1,4,0)
 ;;=4^D05.92
 ;;^UTILITY(U,$J,358.3,15416,2)
 ;;=^5001937
 ;;^UTILITY(U,$J,358.3,15417,0)
 ;;=D05.91^^56^644^42
 ;;^UTILITY(U,$J,358.3,15417,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15417,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,15417,1,4,0)
 ;;=4^D05.91
 ;;^UTILITY(U,$J,358.3,15417,2)
 ;;=^5001936
 ;;^UTILITY(U,$J,358.3,15418,0)
 ;;=D05.90^^56^644^38
 ;;^UTILITY(U,$J,358.3,15418,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15418,1,3,0)
 ;;=3^Carcinoma in Situ Breast Unspec,Unspec Type
 ;;^UTILITY(U,$J,358.3,15418,1,4,0)
 ;;=4^D05.90
 ;;^UTILITY(U,$J,358.3,15418,2)
 ;;=^5001935
 ;;^UTILITY(U,$J,358.3,15419,0)
 ;;=D51.0^^56^644^208
 ;;^UTILITY(U,$J,358.3,15419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15419,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia d/t Intrinsic Factor Deficiency
 ;;^UTILITY(U,$J,358.3,15419,1,4,0)
 ;;=4^D51.0
 ;;^UTILITY(U,$J,358.3,15419,2)
 ;;=^5002284
 ;;^UTILITY(U,$J,358.3,15420,0)
 ;;=D51.1^^56^644^209
 ;;^UTILITY(U,$J,358.3,15420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15420,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia d/t Selective Vit B12 Malabsorp w/ Proteinuria
 ;;^UTILITY(U,$J,358.3,15420,1,4,0)
 ;;=4^D51.1
 ;;^UTILITY(U,$J,358.3,15420,2)
 ;;=^5002285
 ;;^UTILITY(U,$J,358.3,15421,0)
 ;;=D51.9^^56^644^211
 ;;^UTILITY(U,$J,358.3,15421,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15421,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,15421,1,4,0)
 ;;=4^D51.9
 ;;^UTILITY(U,$J,358.3,15421,2)
 ;;=^5002289
 ;;^UTILITY(U,$J,358.3,15422,0)
 ;;=D68.0^^56^644^213
 ;;^UTILITY(U,$J,358.3,15422,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15422,1,3,0)
 ;;=3^Von Willebrand's Disease
 ;;^UTILITY(U,$J,358.3,15422,1,4,0)
 ;;=4^D68.0
 ;;^UTILITY(U,$J,358.3,15422,2)
 ;;=^127267
 ;;^UTILITY(U,$J,358.3,15423,0)
 ;;=C88.0^^56^644^214
 ;;^UTILITY(U,$J,358.3,15423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15423,1,3,0)
 ;;=3^Waldenstrom Macroglobulinemia
 ;;^UTILITY(U,$J,358.3,15423,1,4,0)
 ;;=4^C88.0
 ;;^UTILITY(U,$J,358.3,15423,2)
 ;;=^5001748
 ;;^UTILITY(U,$J,358.3,15424,0)
 ;;=C91.02^^56^644^3
 ;;^UTILITY(U,$J,358.3,15424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15424,1,3,0)
 ;;=3^Acute Lymphoblastic Leukemia,In Relapse
 ;;^UTILITY(U,$J,358.3,15424,1,4,0)
 ;;=4^C91.02
 ;;^UTILITY(U,$J,358.3,15424,2)
 ;;=^5001764
 ;;^UTILITY(U,$J,358.3,15425,0)
 ;;=C92.02^^56^644^6
 ;;^UTILITY(U,$J,358.3,15425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15425,1,3,0)
 ;;=3^Acute Myeloblastic Leukemia,In Relapse
 ;;^UTILITY(U,$J,358.3,15425,1,4,0)
 ;;=4^C92.02
 ;;^UTILITY(U,$J,358.3,15425,2)
 ;;=^5001791
 ;;^UTILITY(U,$J,358.3,15426,0)
 ;;=D09.3^^56^644^50
 ;;^UTILITY(U,$J,358.3,15426,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15426,1,3,0)
 ;;=3^Carcinoma in Situ of Thyroid/Oth Endocrine Glands
 ;;^UTILITY(U,$J,358.3,15426,1,4,0)
 ;;=4^D09.3
 ;;^UTILITY(U,$J,358.3,15426,2)
 ;;=^5001955
 ;;^UTILITY(U,$J,358.3,15427,0)
 ;;=C22.0^^56^644^91
 ;;^UTILITY(U,$J,358.3,15427,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15427,1,3,0)
 ;;=3^Hepatocellular Carcinoma
 ;;^UTILITY(U,$J,358.3,15427,1,4,0)
 ;;=4^C22.0
 ;;^UTILITY(U,$J,358.3,15427,2)
 ;;=^5000933
 ;;^UTILITY(U,$J,358.3,15428,0)
 ;;=C24.9^^56^644^118
 ;;^UTILITY(U,$J,358.3,15428,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15428,1,3,0)
 ;;=3^Malig Neop Biliary Tract,Unspec
 ;;^UTILITY(U,$J,358.3,15428,1,4,0)
 ;;=4^C24.9
 ;;^UTILITY(U,$J,358.3,15428,2)
 ;;=^5000942
 ;;^UTILITY(U,$J,358.3,15429,0)
 ;;=C50.922^^56^644^142
 ;;^UTILITY(U,$J,358.3,15429,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15429,1,3,0)
 ;;=3^Malig Neop Left Male Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,15429,1,4,0)
 ;;=4^C50.922
 ;;^UTILITY(U,$J,358.3,15429,2)
 ;;=^5133340
 ;;^UTILITY(U,$J,358.3,15430,0)
 ;;=C34.91^^56^644^160
 ;;^UTILITY(U,$J,358.3,15430,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15430,1,3,0)
 ;;=3^Malig Neop Right Bronchus/Lung,Unspec Part
 ;;^UTILITY(U,$J,358.3,15430,1,4,0)
 ;;=4^C34.91
 ;;^UTILITY(U,$J,358.3,15430,2)
 ;;=^5000967
 ;;^UTILITY(U,$J,358.3,15431,0)
 ;;=C50.921^^56^644^164
 ;;^UTILITY(U,$J,358.3,15431,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15431,1,3,0)
 ;;=3^Malig Neop Right Male Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,15431,1,4,0)
 ;;=4^C50.921
 ;;^UTILITY(U,$J,358.3,15431,2)
 ;;=^5001198
 ;;^UTILITY(U,$J,358.3,15432,0)
 ;;=C90.02^^56^644^176
 ;;^UTILITY(U,$J,358.3,15432,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15432,1,3,0)
 ;;=3^Multiple Myeloma,In Relapse
 ;;^UTILITY(U,$J,358.3,15432,1,4,0)
 ;;=4^C90.02
 ;;^UTILITY(U,$J,358.3,15432,2)
 ;;=^5001753
 ;;^UTILITY(U,$J,358.3,15433,0)
 ;;=D51.9^^56^644^25
 ;;^UTILITY(U,$J,358.3,15433,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15433,1,3,0)
 ;;=3^Anemia in Vitamin B12 Deficiency
 ;;^UTILITY(U,$J,358.3,15433,1,4,0)
 ;;=4^D51.9
 ;;^UTILITY(U,$J,358.3,15433,2)
 ;;=^5002289
 ;;^UTILITY(U,$J,358.3,15434,0)
 ;;=C79.51^^56^644^35
 ;;^UTILITY(U,$J,358.3,15434,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15434,1,3,0)
 ;;=3^Bone Mets
 ;;^UTILITY(U,$J,358.3,15434,1,4,0)
 ;;=4^C79.51
 ;;^UTILITY(U,$J,358.3,15434,2)
 ;;=^5001350
 ;;^UTILITY(U,$J,358.3,15435,0)
 ;;=C80.1^^56^644^171
 ;;^UTILITY(U,$J,358.3,15435,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15435,1,3,0)
 ;;=3^Malig Neop,Primary,Unspec Site
 ;;^UTILITY(U,$J,358.3,15435,1,4,0)
 ;;=4^C80.1
 ;;^UTILITY(U,$J,358.3,15435,2)
 ;;=^5001389
 ;;^UTILITY(U,$J,358.3,15436,0)
 ;;=C80.0^^56^644^172
 ;;^UTILITY(U,$J,358.3,15436,1,0)
 ;;=^358.31IA^4^2
